Apollomics, Inc. (APLM) vs Rani Therapeutics Holdings, Inc. (RANI)
A side-by-side comparison of Apollomics, Inc. and Rani Therapeutics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$22.10HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RANI
Rani Therapeutics Holdings, Inc.
$0.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — APLM vs RANI
growth of $100 · dividends reinvested · last 5yAPLM -97.6% (-52.8%/yr)RANI -97.5% (-52.3%/yr)RANI compounded faster over this window
APLM RANI
APLM vs RANI: by the numbers
- •RANI is the larger company ($54M vs $49M market cap).
- •Both run net losses; APLM's is the smaller (-128.69% vs -618.02% net margin).
- •APLM grew revenue faster over the past five years (35.84% vs 9.95% CAGR).
Metrics side by side
Valuation
| Metric | APLM | RANI |
|---|---|---|
| P/S ratio | N/A | 11.10 |
| P/B ratio | N/A | 1.38 |
Profitability
| Metric | APLM | RANI |
|---|---|---|
| Gross margin | 97.00% | 44.89% |
| Operating margin | -111.45% | -2345.99% |
| Net margin | -128.69% | -618.02% |
| ROE | N/A | -76.82% |
| ROIC | -2441.49% | -63.96% |
Growth (annualized)
| Metric | APLM | RANI |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | 9.95% |
| Total return CAGR (5Y) | N/A | -46.70% |
Frequently asked
- Which has grown faster, APLM or RANI?
- Over the past five years, APLM grew revenue faster — APLM at a 35.84% CAGR versus RANI at 9.95%.
Go deeper
Dig into the metrics
Apollomics ROERani Therapeutics ROEApollomics operating marginRani Therapeutics operating marginApollomics revenue growthRani Therapeutics revenue growthApollomics free cash flowRani Therapeutics free cash flow
Apollomics & Rani Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.